BioNTech

BioNTech is a German biotechnology company that gained international recognition for its pioneering work on mRNA-based therapeutics and vaccines. Established in 2008, the company became a leading player in the fight against COVID-19 through its partnership with Pfizer to develop the BNT162b2 vaccine, one of the first vaccines authorized for emergency use against the virus. BioNTech's innovative approach and rapid development timeline during the pandemic have positioned it as a key player in the pharmaceutical industry.